Using 91 GBM samples, it was shown that the RTKs, hepatocyte growth factor receptor (encoded by c-Met) and platelet-derived growth factor receptor-α (PDGFRA), are aberrantly activated in 4% and 13% of GBM cases, respectively [21]. The gene discussed is PDGFRA; the disease is glioblastoma.